In re: Dr. Lakshmi ARUNACHALAM, Petitioner.
No. 15-3569
United States Court of Appeals, Third Circuit
January 28, 2016
Submitted Pursuant to Rule 21, Fed. R. App. P. Dec. 10, 2015.
Facen does not argue that the evidence was insufficient to show that he used 303 Lakeview for a drug-related purpose. Rather, he argues that, because courts have continued to rely on pre-2003 case law in analyzing
CONCLUSION
For the foregoing reasons we AFFIRM the district court‘s judgment to the extent that it sustained the jury‘s finding that Facen possessed ammunition and a small bag of cocaine with intent to distribute, VACATE the district court‘s judgment of acquittal with respect to the 34.49 grams of cocaine found in the white shorts and Facen‘s conviction under
Joseph M. Beauchamp, Esq., Houston, TX, Tharan G. Lanier, Esq., East Palo Alto, CA, Counsel for Respondent, Citizens Financial Group, Inc.
Before FISHER, JORDAN and VANASKIE, Circuit Judges.
OPINION AND ORDER OF THE COURT
PER CURIAM.
Dr. Lakshmi Arunachalam has filed a petition for a writ of mandamus seeking an order requiring the disqualification of a District Judge. We conclude that we lack jurisdiction over the petition and will direct the Clerk to transfer it to the United States Court of Appeals for the Federal Circuit.
Arunachalam is a plaintiff in a number of related patent infringement actions that are or were pending in the United States District Court for the District of Delaware. Her complaints invoke the District Court‘s jurisdiction under
In the actions at issue here, Arunachalam filed motions to disqualify the District Judge on the basis of the District Judge‘s ownership of mutual funds that have holdings in certain of the defendant corporations. The District Judge denied the motions by issuing the same memorandum and order in each action on March 28, 2015. Arunachalam now challenges that ruling by seeking a writ of mandamus from this Court ordering the District Judge‘s disqualification.
A District Judge‘s denial of a disqualification is properly reviewable by mandamus, at least when disqualification is sought under
For this reason, the only Courts of Appeals to have addressed the issue have concluded that they lack jurisdiction to issue writs of mandamus in patent infringement actions over which the Federal Circuit has exclusive appellate jurisdiction. See Lights of Am., Inc. v. U.S. Dist. Ct., 130 F.3d 1369, 1370-71 (9th Cir.1997) (per curiam); In re BBC Int‘l, Ltd., 99 F.3d 811, 813 (7th Cir.1996). Those courts concluded that, when the Federal Circuit has exclusive appellate jurisdiction, the Federal Circuit has exclusive mandamus jurisdiction as well. See Lights of Am., 130 F.3d at 1371; In re BBC Int‘l, Ltd., 99 F.3d at 813. The Federal Circuit agrees that it has exclusive mandamus jurisdiction in patent infringement actions, see In re Princo Corp., 478 F.3d 1345, 1351 (Fed. Cir.2007), and it regularly exercises that jurisdiction to entertain disqualification-based mandamus petitions like the one that Arunachalam filed here, see, e.g., In re Beyond Innovation Tech. Co., 166 Fed. Appx. 490, 491-92 (Fed.Cir.2006). Decisions by other courts in analogous contexts are in accord.2 We agree with these deci
Arunachalam argues that we have jurisdiction over her petition pursuant to the residual jurisdictional statute, which provides in relevant part that, “[e]xcept as provided in section[ ] ... 1295 of this title, appeals from reviewable decisions of the district ... courts shall be taken ... to the court of appeals for the circuit embracing the district[.]”
Arunachalam‘s reliance on these authorities is misplaced. In the first place, the residual jurisdictional statute applies by its terms only to “appeals,” and a mandamus proceeding is not an “appeal.” See Madden v. Myers, 102 F.3d 74, 77 (3d Cir.1996). We could construe Arunachalam‘s mandamus petition as a notice of appeal if appropriate, but there is no reason to do so because construing it as a notice of appeal would merely subject it to dismissal for other reasons as noted in the margin.3
Medtronic AVE is inapposite as well. In that case, we concluded that we had appellate jurisdiction to review an interlocutory but immediately appealable order denying a stay of a patent infringement action pending arbitration. See Medtronic AVE, 247 F.3d at 52-53. We acknowledged that, under
In the mandamus context, by contrast, our analysis is indeed confined by that very provision. Because we may issue writs of mandamus only “in aid of” our jurisdiction, and because we will not possess appellate jurisdiction over the final
For these reasons, it is hereby ORDERED that the Clerk transfer the mandamus petition to the United States Court of Appeals for the Federal Circuit. See
